Zonisamide Capsule
Product Images NDC 60687-230

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Zonisamide (NDC 60687-230). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ahp23001

Zonisamide 100 mg oral capsules consisting of a red and white capsule imprinted with "100 mg" on the red half and "IG 228" on the white half. The image shows two capsules, one with both imprints visible and one with no visible imprint. Manufactured by American Health Packaging.*

FDA Label Image

Blister

Packaging labels for Zonisamide Capsule USP 100 mg by American Health Packaging. Each label includes the product name, strength, dosage form, a barcode, and placeholder text for lot number and expiration date. The labels are arranged in a grid on the sheet.*

FDA Label Image

Carton

Zonisamide Capsules, USP 100 mg label from American Health Packaging. The label specifies 100 capsules per container, arranged as 10 blister cards of 10 capsules each. It includes storage instructions, pharmacist dispensing information, and manufacturer details. The product NDC is 60687-230-01, intended for prescription use only.*

FDA Label Image

Figure 1

A line graph comparing percentage reduction in all partial seizures rate between patients treated with Zonisamide capsules and those given placebo. The x-axis shows the percent of patients, and the y-axis shows the percentage reduction in seizures rate with directions for improvement, no change, and worsening. The graph features two curves, one for Zonisamide capsules and one for placebo, illustrating seizure rate changes across patient groups.*

FDA Label Image

Structure

Chemical structure of the active ingredient Zonisamide, showing its molecular framework including a benzisoxazole ring and a sulfonamide group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.